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ABSTRACT
Mass spectrometry allows the elucidation of mo-
lecular details of the interaction domains of the in-
dividual components in macromolecular complexes
subsequent to cross-linking of the individual com-
ponents. Here, we applied chemical and UV cross-
linking combined with tandem mass-spectrometric
analysis to identify contact sites of the nuclear
import adaptor snurportin 1 to the small ribonucleo-
protein particle U1 snRNP in addition to the known
interaction of m3G cap and snurportin 1. We were
able to define previously unknown sites of protein–
protein and protein–RNA interactions on the mo-
lecular level within U1 snRNP. We show that
snurportin 1 interacts with its central m3G-cap-
binding domain with Sm proteins and with its
extreme C-terminus with stem-loop III of U1
snRNA. The crosslinking data support the idea of a
larger interaction area between snurportin 1 and U
snRNPs and the contact sites identified prove useful
for modeling the spatial arrangement of snurportin 1
domains when bound to U1 snRNP. Moreover, this
suggests a functional nuclear import complex that
assembles around the m3G cap and the Sm proteins
only when the Sm proteins are bound and arranged
in the proper orientation to the cognate Sm site in U
snRNA.
INTRODUCTION
Owing to the recently achieved improvements in protein-
analytical techniques—in particular, in mass-spectro-
metric (MS) analysis—cross-linking is one method of
choice for the direct identiﬁcation of interacting compo-
nents and their regions of interaction. The latter proves
particularly useful in the absence of high-resolution
overall structures, and when only partial structure infor-
mation or the structure of only one component is
available.
In this manner, various macromolecular interactions
have been elucidated, including the spatial rearrangement
of protein complexes (1–4), the tertiary folding of RNA
(5), the stoichiometry and protein–protein interactions
within larger macromolecular assemblies such as the
exosome complex from yeast (6) and protein–DNA
(7–10) and protein–RNA (11–14) interactions.
Here we used MS to investigate the quaternary struc-
ture of the U1 small nuclear ribonucleoprotein (U1
snRNP) complex together with the bound nuclear
import factor snurportin1 (SPN1) after protein–protein
and protein–RNA cross-linking. UsnRNPs (U1, U2,
U4/U6.U5) are the key molecules in eukaryotic
pre-mRNA splicing. They associate with numerous other
spliceosomal proteins in a stepwise manner on the
pre-mRNA. U snRNPs consist of a uridine-rich small
nuclear RNA (U snRNA) and a set of particle-speciﬁc
proteins. Common to all UsnRNPs is a set of seven
small, evolutionarily conserved proteins, the so-called
Sm proteins (B/B0, D1, D2, D3, E, F and G). These
seven proteins share a common conserved fold (15,16)
through which they form a heptameric ring-like structure
(17,18). This Sm ring is tightly associated with the
conserved Sm site motif (PuAU4-6GPu) of the
UsnRNAs (19) and generate the so-called Sm core
(20,21).
In eukaryotic splicing, the U1 snRNP is crucial for rec-
ognition of the 50 splice site (SS) of pre-mRNA, which is
achieved by base pairing of the 50-end U1 snRNA with the
50 SS. The base pairing is strengthened by additional
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of the serine–arginine (SR) protein family and the U1
snRNP-speciﬁc protein C and (22). Due to its moderate
protein complexity, the U1 snRNP is the best
characterized snRNP particle in terms of the cell biologic-
al function of the various RNA stem-loops, protein–RNA
interaction at the stem-loops, and its overall structure.
Very recently, Pomeranz Krummel et al. (23) published
the three-dimensional structure of partly truncated
U1snRNPs, derived from crystallization of reconstituted
particles. The overall structure reveals the location of the
50-end of the U1snRNA, the Sm ring on the U1snRNA
and the U1-speciﬁc proteins U1-A, U1-70K and U1-C.
Notably, the determination of the structures—with a reso-
lution of only >5A ˚ —made use of protein–protein and
protein–RNA cross-linking data from previous biochem-
ical and structural studies to ﬁt the U1-speciﬁc proteins
[e.g. the U1-70K, (23)] and the Sm proteins (22,24) into
the overall structure.
In higher eukaryotes, with the exception of U6, the bio-
genesis of all other UsnRNPs requires a cytoplasmic mat-
uration step in which the Sm proteins are assembled with
the help of the ‘survival motor neuron’ complex [SMN
complex, (20,21,25–29)] at the Sm site. Moreover, the
monomethylated 50 cap of the UsnRNA (which was
added co-transcriptionally in the nucleus) is converted
into a trimethylguanosine (TMG) cap (m3G cap) by the
action of hypermethylase trimethylguanosine synthetase 1
(Tgs1) (30,31). The TMG is one element of a nuclear lo-
calization signal within the UsnRNP core that is required
for the import of the assembled U snRNPs into the
nucleus (32). It is speciﬁcally recognized and bound by
the UsnRNP import adaptor SPN1, which bridges the
interaction to the actual import receptor importin-b (33).
It is suggested that importin-b in complex with Sm
proteins bound to U1 snRNA and SMN generates an
import-competent snRNP complex that enters the
nucleus (34). After import into the nucleus the complex
dissociates, and the U1snRNP becomes fully assembled
and can participate in eukaryotic pre-mRNA splicing
through recognition of the 50 SS in pre-mRNAs (35).
SPN1 comprises three distinct domains: an N-terminal
importinb-binding domain, a central m3G-cap-binding
domain, and C-terminal residues so far found to be
involved only in binding the export receptor CRM1
[(32,36,37); see also Figure6]. To date, the only known
interaction between SPN1 and U1snRNP was the
binding of the 50-TMG cap of the UsnRNA to SPN1
(32,37,38). Recent crystallographic and cross-linking
studies have shown that the central domain of SPN1, en-
compassing residues 97–300, binds the TMG, and it has
therefore been termed TMG-binding domain (32,37–39).
The TMG-binding domain harbors two tryptophane
residues, namely 107 and 276, which are in direct
contact with the TMG cap (37). The N-terminal part of
SPN1 (positions 1–65) is important for the interaction
with the import factor importin-b (40–43) as well as for
the binding of SPN1 to the export receptor CRM1 (36).
Additional biochemical and structural analysis
demonstrated that for binding of the m3G cap the
N-terminal part and the 60C-terminal residues could be
omitted (32,37). Interestingly, despite the fact that the
N-terminal domain of SPN1 interacts with CRM1 and
that in the co-crystal structure of SPN1 bound to CRM1
the majority of the C-terminus is non-structured, the
extreme C-terminal 12 residues of SPN1 have been
shown to interact with CRM1 too and are thus structured.
Whether these C-terminal residues are also involved in the
interaction with other elements of U snRNPs is not
known. Furthermore, it is unknown whether SPN1
makes additional contacts with core components of
U1snRNPs (Sm proteins and U1snRNA) or is merely
in close proximity to them.
In this study, we are able to extend the structural model
of U1snRNP by mass-spectrometric mapping of the inter-
action regions between the import factor SPN1 and the
U1snRNA and the Sm proteins B and D3 as well as the
interaction sites between the Sm protein D2 to U1 70K
protein. The combination of protein–protein and protein–
RNA cross-linking in native U1snRNP bound to SPN1
and the detection of interacting regions between the com-
ponents by mass spectrometry provides yet another
example of the analytical power of mass spectrometry in
structural research and in the elucidation of the spatial
arrangement of components within large molecular
assemblies. Furthermore, protein–protein cross-linking
by using heterobifunctional reagents has turned out to
be highly speciﬁc in mapping the spatial arrangement of
proteins within a complex and also identiﬁes such domains
in proteins that were hitherto not known to be involved in
protein–protein interactions.
MATERIALS AND METHODS
Puriﬁcation of native U1snRNA, U1snRNPs and
recombinant SPN1, reconstitution of [U1snRNP–SPN1]
U1snRNPs were puriﬁed from HeLa nuclear extract with
mAb H20 (44) by standard procedures (45). Native
U1snRNA was isolated from U1snRNPs after treatment
of U1snRNPs with proteinase K (ﬁnal concentration
0.5mg/ml) in the presence of 1% (v/v) SDS for 90min
at 37 C. RNA was extracted by chloroform/phenol treat-
ment and precipitated from the aqueous phase with
ethanol. Pellets were washed with 80% ethanol and
dried in a SpeedVac. The sample was puriﬁed by
urea-gel electrophoresis. Bands containing U1snRNA
were excised, and RNA was eluted with TNES buﬀer
(20mM Tris–HCl, pH 8.0; 300mM NaCl; 5mM EDTA;
0.1% SDS) and further extracted with chloroform/phenol
as described above. SPN1 was puriﬁed as described by
Strasser et al. (39).
Reconstituted [U1snRNP–SPN1] was obtained by
incubating 1.7nmol recombinant SPN1 with 0.25 nmol
native U1snRNPs for 10min on ice and then loading
the mixture onto a Superdex 200 PC column (PC 3.2/30)
running in SE buﬀer (20mM Hepes–KOH, pH7.9;
150mM NaCl; 1.5mM MgCl2) at a ﬂow rate of
40ml/min. The maximum sample volume per run was
50ml. Fractions containing [U1snRNP–SPN1] complexes
were subsequently used for protein–protein cross-linking
(see below). Alternatively, for protein–RNA cross-linking,
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incubating 1.2nmol ( 60mg) recombinant SPN1 with
0.4nmol (70mg) native U1snRNPs for 30min on ice,
and directly subjecting the complex to UV irradiation
(see below). For large-scale cross-linking of SPN1 to
native U1snRNA, 5nmol of U1snRNA was incubated
with  12nmol recombinant SPN1 and processed as
described below.
UV cross-linking and ESI and MALDI
mass-spectrometric analysis of cross-linked
peptide–oligonucleotides
Reconstituted [U1snRNP–SPN1] and/or native
U1snRNA reconstituted with SPN1 were cross-linked at
a concentration of 0.1–0.2mg/ml according to
Ku ¨ hn-Ho ¨ lsken et al. (46) in a volume of 1ml (analytical
scale) or 12.5ml (preparative scale). UV cross-linking was
carried out on ice for 5min at a wavelength of 254nm and
the sample was further processed (precipitation with
ethanol, trypsin digestion and puriﬁcation by
size-exclusion chromatography) as described by Ku ¨ hn-
Ho ¨ lsken et al. (46). RNA-containing fractions were
hydrolyzed with RNase A and T1, and subjected to LC-
coupled tandem mass-spectrometric analysis on a hybrid
triple quadrupole/linear ion-trap mass spectrometer (4000
QTRAP LC/MS/MS System, Applied Biosystems/MDS
Analytical Technologies) coupled to a Tempo 1D nano
LC System (Applied Biosystems/MDS Analytical
Technologies). Chromatography, initial detection of the
cross-links in negative ion mode by precursor-ion
scanning and subsequent veriﬁcation and structural
analysis of peptide–RNA oligonucleotide cross-links in
positive ion mode by Multiple Reaction Monitoring
(MRM)-triggered product ion-scanning experiments
were performed exactly as described recently (11).
MALDI-MS/MS analysis of peptide–RNA cross-links
was performed after semi-preparative puriﬁcation of
cross-links derived from UV-irradiated [U1snRNA–
SPN1] on a microbore liquid chromatography system
(SMART, GE Healthcare) as described by Ku ¨ hn-
Ho ¨ lsken et al. (46). Puriﬁed fractions that contained
cross-linked peptide–RNA oligonucleotides were mixed
with DHB (10mg/ml) as matrix and analyzed on a
MALDI-ToF/ToF mass spectrometer (4800
MALDI-TOF/TOF Analyzer, Applied Biosystems/MDS
Analytical Technologies) under standard conditions in
positive-ion mode.
Enrichment of cross-linked peptide–RNA oligonucleo-
tides by immobilized metal-aﬃnity chromatography
(IMAC) was performed after treatment of cross-linked
[U1snRNA–SPN1] complexes with trypsin and RNases
A and T1 and separation of the products on a capillary
LC system (140C microgradient system, Applied
Biosystems). Capillary LC separation and subsequent
IMAC enrichment and elution of bound species were
carried out exactly according to Ku ¨ hn-Ho ¨ lsken et al.
(14). Enriched species were analyzed by MALDI-ToF
mass spectrometry (Reﬂex IV, Bruker) using DHB as
matrix.
Sulfo–MBS cross-linking and MALDI-mass spectrometric
analysis of cross-linked peptides
Cross-linking of reconstituted and puriﬁed [U1snRNP–
SPN1] complexes was performed with 5mM sulfo-MBS
(Pierce) for 30min at room temperature (47). The
cross-linking reaction was stopped by adding DTT and
Gly-HCl to a ﬁnal concentration of 10and 5mM, respect-
ively, for 30min at 37 C. Cross-linked samples were
precipitated with 5 volumes of acetone, washed with
80% ethanol and dried in a SpeedVac. Pellets were
dissolved in SDS sample buﬀer (with DTT) and loaded
onto SDS-polyacrylamide gels. After electrophoresis,
Coomassie-stained bands were excised, and cross-linked
proteins were digested with trypsin according to
Shevchenko et al. (48), except that no DTT/iodoacetamide
treatment was performed. Peptides were extracted and
separated on C18 reversed phase (RP) column (Nucleosil
100-5 C18, 200 0.075mm, 5mm, 100A ˚ ,
Macherey-Nagel) under standard conditions using aceto-
nitrile (ACN) in water with 0.1% (v/v) triﬂuoroacetic acid
as eluent, with a gradient from 7.5 to 37.5% ACN in 0.1%
formic acid over 60min; the ﬂow rate was 250ml/min.
Eluting species were mixed on-line with a-cyano-4-
hydroxycinnamic acid (CHCA, 10mg/ml). 15-second frac-
tions were collected with a Probot microfraction collector
(LC Packings) on a stainless steel MALDI target and
analyzed by using a MALDI-ToF/ToF mass spectrometer
(4800 MALDI-TOF/TOF Analyzer, Applied Biosystems/
MDS Analytical Technologies).
RESULTS
Protein–protein contacts between SPN1 and U1snRNP
To investigate in detail how SPN1 interacts with native U1
snRNP, we ﬁrst puriﬁed [U1 snRNP–SPN1] complex by
size exclusion chromatography (SE) after incubation of
puriﬁed native U1 snRNPs with recombinant SPN1
(Figure 1A). The respective SDS-PAGE analysis of the
corresponding SE fraction showed that SPN1 forms a
stable complex with U1 snRNP that elutes in fraction
2 and 3 and can be clearly separated from non-bound
SPN1 (fractions 4–9, Figure 1A). Moreover, the
SDS-PAGE analysis with silver staining of the proteins,
although not strictly quantitative, revealed that SPN1 is
bound to U1 snRNP probably in an equimolar manner
(Figure 1A, lower panel). Fractions containing the
complex were incubated with the cross-linking reagent
sulfo-MBS and after precipitation of the thus probed
complex, SPN1 and U1 snRNP proteins are separated
by SDS-PAGE (Figure 1B). The chosen cross-linking
reagent sulfo-MBS is a water-soluble heterobifunctional
cross-linker consisting of an N-hydroxysuccinimide
(NHS) ester and a maleimide group that links amines
(e.g. e-Lys) and sulfhydryl groups (e.g. Cys), thereby
generating a covalent spacer of  7.3A ˚ between the
cross-linked species. Sulfo-MBS has been used successfully
in earlier studies to demonstrate the close proximity of the
U1-speciﬁc proteins SmD3 to SmB/B0, 70K to SmD2 and
U1-70K to protein C of the U1snRNP (48).
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omitted in the cross-linking experiments (Figure 1B, lane
1), treatment of U1 snRNP and the [U1snRNP–SPN1]
complex resulted in several additional protein bands that
represent potential cross-linked protein species (Figure 1B,
compare lanes 2 and 3). Routine ESI-MS analysis revealed
that the most prominent bands correspond to cross-linked
U1-70K–D2, and the weaker ones to SmB/B0–SmD3, and
U1 70K–Sm B/B0 as identiﬁed in earlier studies by western
blot analysis (48) (data not shown). In the band migrating
below the double cross-link band corresponding to U1
70K–Sm B/B0 we could only detect U1 70K by MS. This
band might correspond to a U1 70K–U1 C cross-link as
detected in earlier studies albeit with a diﬀerent
cross-linking reagent, i.e. DSB (49). The fact that we
could not detect any other peptides suggests tentatively
that the other cross-linked protein could be U1 C. It is
known that U1 C produces only a very limited number of
tryptic fragments and readily escapes detection by MS or
is identiﬁed by 1 peptide only even when a large amount
of U1 C is analyzed (50). In addition, two hitherto
uncharacterized bands migrating at 40–50kDa were
detected in cross-linked [U1snRNP–SPN1] (Figure 1B,
lane 3, bands II and III) that are not observed in
cross-linking studies using U1snRNP only suggesting
that these contain SPN1 cross-linked to U1 snRNP
speciﬁc proteins. Routine ESI-MS analysis identiﬁed
SNP1 and Sm proteins within these bands.
These together with the U1 70K–D2 band (Figure 1B,
lane 1, band I) were analyzed in more detail by LC-oﬄine
MALDI MS/MS in order to identify the actual
cross-linked peptide regions. Of note, the other weaker
bands with cross-linked proteins were not further
investigated mainly owing to the fact that their intensity
was too weak to expect sequence information of the
cross-linked protein regions of the corresponding
proteins. To identify cross-linked peptides, the MS and
MSMS spectra of those precursors that did not match
with the peptide sequences of any U1snRNP-speciﬁc
protein and/or SPN1 (including all possible protein modi-
ﬁcations) in the database search were inspected more
closely. Potential peptide–peptide cross-links should
display m/z values consistent with the masses of the
cross-linked peptides and the mass increment of 199Da
Figure 1. (A) Puriﬁcation of the [U1snRNP-SPN1] complex. SPN1 and U1 snRNPs mixed in a 7 to 1 molar ratio were incubated on ice for
10minutes prior to removal of excess of unbound SPN1 by size exclusion chromatography (SE). The fractions obtained were analyzed by SDS–
PAGE and visualized by Silver staining. Upper Panel: Chromatogram of the SE elution. Lower panel: Proteins in the respective fractions were
separated by SDS–PAGE. Fractions 2 and 3 containing the [U1snRNP-SPN1] complex were used for subsequent cross-linking experiments. Of note,
U1 70K protein escapes detection by silver staining (45). (B) Protein–protein cross-linking of reconstituted [SPN1–U1snRNP] complexes using
sulfo-MBS. Sulfo-MBS-induced protein–protein cross-links were analyzed by SDS-PAGE and subsequently stained with Coomassie. Lane 1,
non-cross-linked [U1snRNP-SPN1]; lane 2, cross-linked [U1snRNP] using 5mM sulfo-MBS; lane 3, cross-linked [U1snRNP-SPN1] using 5mM
sulfo-MBS. The positions of the individual U1 snRNPs proteins are indicated. Previously identiﬁed U1 70K–SmD2 (marked with I), U1 70K-Sm
B/B0, and SmB–SmD3 cross-linked species are indicated (*). A potential cross-link of U1 70K with presumably U1 C protein is indicated as well.
Arrows II and III mark additional putative protein–protein cross-links that were not observed in previous studies (48) and may thus be expected to
be speciﬁc for SPN1. Lane 4, molecular-weight marker (MW).
5584 Nucleic Acids Research, 2010,Vol.38, No. 16caused by the cross-linker. We ﬁrst annotated those
MSMS spectra derived from the previously identiﬁed
U1-70K–SmD2 cross-link (Figure 1B, lane 1, band I) for
validation of cross-links. After trypsinization and elution
of the peptides, we identiﬁed a precursor at m/z 2557.3
that matched precisely to the U1-70K tryptic fragment
HHNQPYCGIAPYIR (1667.8Da; positions 33–46 of
U1-70K) cross-linked via sulfo-MBS (199.1Da) to the
Sm-D2 tryptic peptide SKPVNK (671.3Da; positions
87–92) plus a water molecule (18.0Da). Maleimides can
add water through hydrolysis, thus being slowly converted
to their cis-maleamic acid derivatives (51). Figure 2A
shows the fragmentation pattern of this precursor. The
product ion spectrum reveals a triplet of fragment ions
resembling the fragmentation of peptides containing di-
sulﬁde bridges, i.e. showing a characteristic loss of 34Da
(–H2S) (52). The fragment ion at m/z 1766.8 corresponds
to the U1-70K tryptic peptide (HHNQPYCGIAPYIR)
with a succinimide attached to the SH group of Cys-39.
Owing to the instability of sulﬁde bonds in MALDI-MS/
MS, a fragment ion corresponding to the non-modiﬁed
peptide (y14, HHNQPYCGIAPYIR in Figure 2A) was
observed. The sequence of the cross-linked peptide was
conﬁrmed by the detection of fragment ions in the lower
Figure 2. MALDI-MS/MS analysis of cross-linked peptides derived from reconstituted [U1snRNP-SPN1] complexes. (A) MALDI product-ion
spectrum of a peptide–peptide cross-link at m/z 2557.3 derived from the cross-linked proteins U1-70K–SmD2 after in-gel trypsinization (Figure
1B, band I). The sequences of the cross-linked peptides (U1-70K, HHNQPYCGIAPYIR; Sm-D2, SKPVNK) with their speciﬁc y-type ions are listed
within the spectrum. (B) MALDI product-ion spectrum of a peptide–peptide cross-link at m/z 1499.7 derived from band II in Figure 1B. MS analysis
identiﬁed SPN1 cross-linked to SmB/B0. The cross-linked sequences from SPN1 (SGYCVNR) and from SmB/B0 (IKPK) are given as insets within
the spectrum. Sequences were determined according to the y-type fragment ions.
Nucleic Acids Research, 2010,Vol.38, No. 16 5585m/z part of the spectrum (see Figure 2A). The sequence of
the cross-linked SmD2 peptide was conﬁrmed by its y4
fragment ion ([PVNK+H]
+, Figure 2A), thus revealing
Lys-88 as the actual cross-linked amino acid. Several
other lysines in the immediate vicinity were also found
to be crosslinked (SGKGKKKSKPVNK, positions 80–
92 of SmD2, cross-linked with Lys-83 and Lys-85–87)
by manual inspection of the corresponding product ion
spectra (data not shown).
Accordingly, the speciﬁc fragmentation pattern of this
particular cross-linked species was then used to scan for
further peptide–peptide cross-links in product ion spectra
derived from bands II and III (Figure 2B), expected to
bear cross-linked SPN1. Indeed, a peptide–peptide
cross-link at m/z 1499.7 corresponding to a tryptic
peptide derived from SPN1 (positions 145–151,
SGYCVNR, 797.4Da) cross-linked via sulfo-MBS
(199.1Da) to an SmB/B0 tryptic peptide (positions 51–
54, IKPK, M.W.:484.3 Da) was detected (Figure 2B).
Note that the measured precursor mass again corresponds
to that of the cross-link after addition of a water molecule
(+18Da) by the hydrolytic cleavage of the succinimide
ring (which still leaves the cross-link intact, see above).
A product ion spectrum of the cross-link precursor
without the addition of water could also be obtained,
but showed weak precursor and fragment ion intensities
(data not shown).
The cross-linked band III in the SDS-PAGE
(Figure 1B, lane 3) was analyzed in the same way and
found to contain a protein–protein cross-link between
SPN1 and SmD3. MSMS analysis showed that the
cross-linking site on SPN1 encompassed the above
peptide SGYCVNR with Cys-148 cross-linked. The
cross-linking peptide in SmD3 was found to be
SMoxKNKNQGSGAGR (positions 85–97, 1349.6Da)
with Lys-87 or -89 cross-linked (data not shown).
Taken together, two novel protein–protein interactions
of SPN1 and proteins of the Sm ring have been identiﬁed,
namely between SPN1 (145–151, Cys-148) and Sm B/B0
(Lys-52) as well as SmD3 (Lys-87 or Lys-89).
Protein–RNA contacts in the U1snRNP–SPN1 complex
A wealth of data is available that show that SPN1 binds
the hypermethylated terminal 50 cap [m3GpppAUA
(TMG)] of U1snRNA in the U1snRNP (32,37,38). The
fact that SPN1 can be cross-linked to Sm proteins in
native U1snRNP raises the intriguing question of
whether SPN1 might also form additional contacts to
U1snRNA apart from its interaction with the 50 cap of
U1snRNP and, if so, which region(s) of SPN1 (besides the
TMG) is/are involved.
To investigate potential protein–RNA contacts between
SPN1 and U1 snRNP on a molecular level, we ﬁrst
applied Electrospray ionization (ESI) MS with multiple
reaction monitoring (MRM). This method has been
proven to be fast and highly sensitive for the speciﬁc de-
tection of peptide-RNA oligonucleotides derived from UV
irradiated samples (11). It is thus ideally suited to rapidly
obtain an overview about potential cross-links in UV
irradiated particles. This particular method is based on
(i) precursor ion scanning experiments in the negative
mode of the MS for detection of phosphate groups con-
taining species (–79Da), i.e. putative peptide-RNA
cross-links derived after hydrolysis of UV irradiated par-
ticles with endoproteinases and nucleases and (ii) MRM
triggered fragmentation of the peptide-RNA cross-linked
species in the positive mode for unambiguous sequence
determination of the cross-linked peptide and RNA
moiety.
Figure 3A shows the precursor ion-scanning experi-
ments of UV irradiated [U1 snRNP–SPN1] after hydroly-
sis of the protein moiety with trypsin and the RNA moiety
with ribonucleases A and T1. Shown are the masses of
those species over LC elution time that produce PO
 
3
ions in the negative mode upon fragmentation in the
MS. The precursor-ion-scanning experiments revealed
Figure 3. Detection and structural analysis of [U1snRNA-SPN1]
cross-links by LC/MS/MS. (A) Precursor-ion-scanning experiments
for m/z 79 (PO
 
3 ) in negative-ion mode to determine the molecular
weight of putative cross-linked species (see text and ‘Materials and
Methods’ section for details). Observed m/z values of PO
 
3 -generating
precursors are plotted against their retention time. The corresponding
molecular weights listed (MW=2042.8Da, 2284.0Da, 2371.9Da and
2613.9Da) are selected in a second experiment for MRM-triggered
MSMS analysis in positive-ion mode (see text and ‘Materials and
Methods’ section for details). (B) MRM-triggered product-ion scan of
a cross-linked precursor (MW=2042.3Da) derived from SPN1. MRM
was triggered by the monitoring production of speciﬁc RNA-base
fragment ions, i.e. [M+nH]
n+ ! [{111, 112, 135, 151}+H]
+. The
sequence of the cross-linked peptide (GSSHSPDHPGCLMEN) with
the corresponding fragment ions is given within the deconvoluted
spectrum. The deciphered sequence shows an extra mass of 476Da
that cannot be explained by any combination of RNA mono- and/or
dinucleotides.
5586 Nucleic Acids Research, 2010,Vol.38, No. 16several putatively cross-linked species that had not been
observed in earlier UV cross-linking experiments with
U1snRNPs (11). The most prominent ones are observed
at m/z values of 2042.8Da., 2284.0Da, 2371.9Da and
2613.2Da, respectively (Figure 3A). These species were
selected for MRM-triggered product ion-scan experiments
to acquire sequence information on the cross-linked
peptides. An example is shown in Figure 3B for the
precursor with the molecular mass of 2042.8Da. The
corresponding peptide GSSHSPDHPGCLMEN (as
identiﬁed by product ion spectra) represents the C-
terminal 15 residues of SPN1 (positions 346–360) with
an ‘extra mass’ of 476Da. MRM-triggered product ion
experiments of the other species also revealed the C-
terminus of SPN1 (2284.8Da, IKGSSHSPDHPGCL-
MEN, positions 344–360, data not shown) and the
C-terminus with a cross-linked adenosine (2371.9Da,
GSSHSPDHPGCLMEN+A (329Da); 2613.2Da,
IKGSSHSPDHPGCLMEN+A). Surprisingly, all
sequencing results revealed an extra mass of 476Da that
does not match with the mass of any (modiﬁed) mono- or
dinucleotide.
Further investigation of these cross-links by ESI-MS
was not possible. MS
3 experiments of a fragment ion con-
taining the extra mass gave no further result about the
nature of the extra mass (data not shown). We therefore
applied matrix assisted laser desorption/ionization
(MALDI)-MSMS as alternative fragmentation strategy
in order to investigate whether the extra mass of 476Da
belonged to a cross-linked RNA moiety. We performed
MALDI product ion-scan experiments (MSMS) on the
cross-linked precursor ([M+H]
+ m/z 2043.8) that was
puriﬁed under semi-preparative conditions for that
purpose [according to (46)]. Product ion-scan analysis
revealed a characteristic neutral loss of H3PO4 (98Da)
and ribose (114Da) under high energy collision-induced
decay (CID) conditions (Figure 4A), demonstrating that
the extra mass must include a ribophosphate moiety.
Additional information about the nature of the puta-
tively cross-linked RNA was obtained by isolation of this
cross-linked species under semi-preparative conditions
combined with strategies to enrich it by immobilized
metal-aﬃnity chromatography [IMAC (14)]. Enrichment
of cross-linked species by IMAC usually facilitates the
detection of the larger hetero-conjugates in the mass spec-
trometer (7,9,14). MALDI-mass spectrometric analysis of
an enriched sample containing the putatively cross-linked
precursor in its methionine-oxidized form ([M+H]
+ m/z
2059.5) demonstrates that this species is derived from a
larger precursor with a cross-linked RNA moiety A3U
([M+H]
+ m/z 3046.1, Figure 4B). Surprisingly, an add-
itional signal corresponding to the non-cross-linked
peptide moiety in its methionine-oxidized state ([M+H]
+
m/z 1583.5Da) was detected as well. This suggests a
stepwise loss of nucleotides and that the occurrence of
the non-cross-linked peptide is due to the acidic elution
conditions of the cross-linked species from the IMAC
beads, i.e. with phosphoric acid. The observed ladder-like
pattern is due to acid hydrolysis of the larger cross-linked
species. Importantly, the mass diﬀerence between m/z
2059.5 (corresponding to GSSHSPDHPGCLoxMEN
plus 476Da) and m/z 1735.5 exactly matches a single
uridine nucleotide plus water and would therefore
explain the loss of phosphate and ribose observed in the
product-ion-scan experiments (Figure 4B). However, both
cross-linked species still reveal a mass diﬀerence of
 152Da that cannot be easily explained, so that its
nature remains unclear (see ‘Discussion’ section).
Despite this ambiguity, there are only two sequence
stretches in U1snRNA that harbor an oligonucleotide
sequence with a nucleotide composition of three As and
one U. These are positions 102–105 in stem-loop III (SL
III, 50AAAUp-30) and positions 123–126 adjacent to the
Sm site (50-AUAAp-30). Importantly, the observed loss of
one uridine plus a water molecule in MALDI-MS argues
that the 30 terminus of the cross-linked oligonucleotide is
Figure 4. IMAC enrichment for the analysis of peptide–RNA oligo-
nucleotide cross-links derived from UV-irradiated [U1snRNP-SPN1]
complexes. (A) MALDI-MSMS analysis of isolated cross-linked precur-
sor (MW=2042.3Da). The fragmentation of the cross-link in the
MALDI reveals that the extra mass is at least partly due to nucleic
acids, as the loss of phosphate and ribose is seen clearly within the
spectrum. Peptide-speciﬁc fragmentation is observed as well. (B)
MALDI MS analysis of an enriched and semi-preparative puriﬁed
cross-link species (see ‘Materials and Methods’ section) encompassing
the cross-linked SPN1 tryptic fragment GSSHSPDHPGCLMoxEN.
The MALDI MS spectrum shows mass signals for the non-cross-
linked oxidized peptide and various corresponding cross-linked
peptide-oligoribonucleotides. The diﬀerences in mass between the
non-cross-linked and cross-linked species that correspond to nucleo-
tides are listed; they reveal the cross-linked RNA moiety (AAAUp).
The cross-link still has an extra mass of  152Da that cannot be ex-
plained (see also text).
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region cross-linked to SPN1.
Taken together, our protein–RNA cross-linking data
demonstrate that the C-terminal region of SPN1 [presum-
ably with C and/or L as the actual cross-linked amino
acid(s)] is cross-linked to SL III of U1snRNA.
DISCUSSION
In order to identify further interactions in [SPN1–
U1snRNP] complexes, we performed protein–protein
and protein–RNA cross-linking studies. Using mass
spectrometry, previously unknown sites of interaction
between SPN1 and U1 Sm core proteins (i.e. the
Sm proteins associated with Sm site RNA) and the
U1snRNA were identiﬁed at the molecular level. We
identiﬁed a SPN1 peptide encompassing positions 145–
151 (SGYCVNR) cross-linked to SmB and SmD3 and a
peptide containing the 15C-terminal residues of SPN1
cross-linked to SL III in U1snRNA. The results provide
valuable information on the site of the U1snRNP that
interacts with SPN1 and on the mutual orientation of
the components of U1snRNP. Our results can be
integrated into the currently available 3D structure of
U1snRNP (23). This work is a further demonstration of
the analytical power of mass spectrometry in protein–
protein and protein–RNA cross-linking studies, and of
the potential of its combination with other structural in-
formation, allowing one to draw conclusions about the
spatial arrangements of components within macromolecu-
lar complexes.
Here we discuss the results in more detail in the context
of (i) technical aspects of UV-induced protein–RNA
cross-linking, (ii) interactions between SPN1, the Sm
core and U1snRNA, (iii) novel cross-linking sites in Sm
proteins and (iv) location of SPN1-binding sites on the
U1snRNP.
Methodical considerations about MS-based detection of
protein–RNA cross-links
Previous mass-spectrometric analysis of UV-induced
cross-links between a protein or peptide and its RNA
revealed that UV cross-linking is additive, i.e. the mass
of the cross-linked product is the sum of the masses of
the cross-linked peptide moiety and the cross-linked
oligoribonucleotide (11–14,53). In the current study, we
identiﬁed the C-terminal tail of SPN1 cross-linked to
SL III of U1snRNA (50-A102AAU105p-30) in a variety of
MS experiments including precursor-ion scanning and
MRM ESI mass spectrometry, as well as MALDI mass
spectrometry after IMAC enrichment of cross-linked
species. In this case, however, the entire mass of the
cross-linked conjugate does not equal the sum of the
masses of the cross-linked peptide
(GSSHSPDHPGCLMEN, MW=1566.6Da) and RNA
(AAAUp, MW=1311.2Da) moieties. We show that
this cross-link harbors an additional mass of  152Da
(151.9572Da as determined by MS on Orbitrap instru-
ment, data not shown). Surprisingly, we have observed a
similar phenomenon in other UV-irradiated RNP
particles, where peptides that harbor a cysteine-residue
are cross-linked to RNA. These were the U4/U6-speciﬁc
protein 61K/hPrp31 bound to U4atac snRNA (H.U. and
M. Wahl, unpublished results) and Sm proteins
cross-linked to U1 and U2 snRNA (H.U. and F.R., manu-
script in preparation). However, the exact chemical nature
of the ‘extra mass’, and thus of this particular cross-link,
still remains unclear as these cysteine-based cross-links
seem to occur exclusively in native particles. A possible
explanation for the crosslink derives from a study
recently published by Chen et al. (54), who showed that
modiﬁed guanosine base is reactive towards cysteine side
chains. Indeed, the cross-linked stretch of U1snRNA in
SL III (50-AAAUp-30) contains a guanosine adjacent to
the uracil (nucleotide position 106 in SL III, 50
102AAAU
G-10630). Moreover, in the crystal structure of the
U4/U6-speciﬁc protein 61K/hPrp31 bound to
U4atacsnRNA the identiﬁed cross-linked cysteine in
61K/hPrp31 is in direct contact with a guanosine in the
50 stem-loop of U4atac snRNA (M. Wahl, personal
communication).
SPN1-U1snRNA and Sm core interactions
Previous biochemical studies have shown that SPN1 inter-
acts with the TMG of U1 snRNA/snRNP (32,38).
Furthermore, UV cross-linking studies revealed that the
TMG cross-links eﬃciently to SPN1, and that the
cross-link cannot be inhibited by U1 snRNA/snRNP
that lacks the 50 TMG. Together, all these previous
results suggest that no additional domain in U1 snRNA/
snRNP contacts SPN1 except for the TMG. On the other
hand, UV induced cross-linking has been demonstrated to
monitor additional molecular interactions that are less
strong and are located apart from the actual
nucleotide-binding domain of a protein as it is for
example shown in the protein–RNA complex consisting
of 61K/hPrp31 and a 15.5K protein bound to the 50
stem-loop of U4 and U4atac snRNA (55,56).
In the present study, we were not able to identify
cross-linked residues or regions in SPN1 encompassing
the TMG-binding site. This was probably due to the fact
that the tryptophan residues 107 and 276 (that are crucial
for the interaction with the TMG) are located in extremely
large tryptic peptides and thus exhibit poor chromato-
graphic and ionization yields, which hamper the detection
of cross-linking within these regions by LC–MS/MS.
Interestingly, we found the C-terminal residues of SPN1
to be cross-linked to SL III of U1snRNA. The
cross-linking is achieved by the last 15 residues of SPN1
and therefore SL III and the TMG-cap of the U snRNA
must be separated by a distance that may be bridged by
the TMG-binding domain and the C-terminus of SPN1
(see below and Figure 6C). The extreme C-terminus of
SNP1 has also been recently shown to bind to CRM1 in
a fully assembled export complex (36), suggesting a
possible dual function of the C-terminal tail of SNP1,
i.e. RNA interaction and binding to the export complex.
It seems that cross-linking of SPN1 to the Sm proteins
requires correct interaction of SPN1 with the TMG of the
U1snRNA, since no protein–protein cross-linking was
5588 Nucleic Acids Research, 2010,Vol.38, No. 16observed when U1snRNPs lacking the TMG were
incubated with an excess of SPN1 and exposed to
cross-linking conditions (data not shown). These results
imply that the speciﬁc binding of SPN1 to the TMG is a
prerequisite for the formation of additional contacts to the
U1snRNP.
The second cross-link site in SPN1 was a peptide
composed of residues 145–151 of SPN1, which cross-link
to residues 51–54 of SmB/B0 [loop 4 according to
Kambach et al. (18); see also Figure 5] and also to the
C-terminal domain of SmD3 (residues 85–97; see
Figure 5). SPN1 residues 145–151 are located within the
TMG-binding domain of SPN1 adjacent to the actual
TMG-binding site (see also Figure 6C), suggesting an add-
itional structural and/or functional role of this domain.
Since this site binds not only to SmB/B0 but also to
SmD3, our data suggest a spatial proximity between the
L4 loop region of SmB/B0 and the C-terminal region of
SmD3. However, the structural analysis of the recombin-
ant partial U1snRNP indicates that precisely these
regions in SmB/B0 and SmD3 are highly ﬂexible, and are
thus missing in the observed structure (22); however, this
does not preclude being close, or adjacent, to one another.
Interestingly, the site of cross-linking of SmD3 to SPN1
is located immediately adjacent to the ﬁrst dimethyl RG
dipeptide in SmD3 (57). Dimethylated RG repeats in the
Sm proteins have been shown to be crucial for the inter-
action with Sm assembly factor SMN (58,59) as this par-
ticular protein interacts with dimethylarginine residues
within RG dipeptide repeats of the Sm proteins B/B0,
D3 and D1 (58,60).
Protein–protein interaction through variable loop regions
of the Sm proteins
Phylogenetic and crystallographic studies initially
demonstrated that the seven eukaryotic Sm proteins
(B/B0, D1, D2, D3, E, F and G) share a common fold
with two evolutionarily conserved motifs, Sm1 and Sm2
(15,16,18; Figure 5). Protein–RNA cross-linking (61) and
crystallographic studies with Sm-like (LSm) proteins from
Archaea (62,63) and Sm homologues from E. coli (64)
with short oligoribonucleotides further demonstrated
that the loop regions connecting b-strands 2 and 3 (loop
L3) and 4 and 5 (loop L5), respectively, together with their
adjacent amino acids from the respective b-strands, are in
contact with the U-rich Sm RNA site.
Little is known about the structural and functional
features of the variable loop regions of the Sm and LSm
proteins that connect the Sm motifs, i.e. loop 4 and its
adjacent b-strand regions. Indeed, this region of the Sm
proteins (together with the C-terminal region of the
proteins, see also below) exhibits the highest variability
among the seven Sm proteins both in sequence and in
size (Figure 5). We were able to show that these regions,
in which the Sm proteins B and D2 are extended, are ac-
cessible to protein–protein cross-linkers, so that SmB is
subsequently cross-linked to SPN1 and SmD2 to
U1-70K (Figures 4 and 5).
Moreover, recent structural studies with the yeast
Sm-like protein LSm3, which forms a homo-octameric
ring, have shown that LSm3 is capable of binding to
other LSm proteins (LSm2, 5 and 6) through interactions
involving the variable region b3–L4–b4 (65). Our
cross-linking data strongly support the assumption of a
composite protein–protein interaction surface encompass-
ing loop 4 and b-strands of the Sm motif, and they thus
add another feature to the loop regions of the Sm fold,
showing that these are involved in protein contacts via
their largely ﬂexible domains (Figure 5).
Overall localization of crosslinked proteins
Remarkable overall structural information, albeit at
moderate to low resolution, has been obtained on native
intact U1snRNPs by electron cryomicroscopy (23) and on
an in vitro assembled truncated, but active form of
U1snRNPs by X-ray crystallography (22). To date, only
the coordinates of the protein C-alpha and RNA phos-
phorus atoms of U1snRNP are available in the databank,
thus preventing any detailed structural interpretation of
our cross-linking experiments or a molecular docking
approach. However, detailed structural information is
available on the individual domains of SPN1 interacting
Figure 5. Location of protein–protein cross-linking sites identiﬁed in Sm proteins. Sequence alignment of the Sm1 and Sm2 motifs of the human Sm
proteins B/B0, D2, D1, D3, E, F and G are according to Hermann et al. (15). The topology of the secondary structure was adapted from the crystal
structures of SmB-D3 and SmD1-D2 protein complexes (18). Conserved amino acids are highlighted as follows: uncharged, hydrophobic residues (L,
I, V, A, F, W, Y, C, M) are in light red; acidic and basic amino acids (D, E, R, K) are in green, and 100% conserved amino acids in dark red.
Secondary structure elements in the Sm proteins are depicted as follows: a=helix; b=beta-sheet, L=loop. Arrows mark the cross-linked amino
acids in the variable loop 4 of the protein sequences of SmD2 and SmB and in the C-terminal part of SmD3.
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N-terminal domain bound to importin b, the central
TMG-cap binding domain in complex with a m3GpppG
dinucleotide, and the C-terminal tail bound to CRM1
(36,37,41,43).
Besides the TMG-cap binding site, the central domain
of SPN1 harbors the newly mapped interaction site for
SmB/B0 and SmD3 (Figure 6B), which are in close prox-
imity within the doughnut-like ring structure of the Sm
proteins in the U1snRNP (Figure 6A and C). The struc-
tural analysis of the recombinant partial U1snRNP indi-
cates that these regions in SmB/B‘ and SmD3 are highly
ﬂexible, and are thus missing in the reported structure [see
above (22)]. Nevertheless, these loops could be arranged in
a conformation that brings the interacting residues into
close proximity to SPN1 (Figure 6C).
Structural information on the C-terminal tail of SPN1 is
available for the last 12 residues bound to CRM1 (36).
The absence of the residues connecting the
TMG-binding domain and these C-terminal residues in
the known structure indicates a high conformational ﬂexi-
bility, suggesting that additional interaction sites could be
at various distances from the TMG-binding domain of
SPN1 (Figure 6B). Interestingly, exactly these same
C-terminal residues in SPN1 have been mapped as inter-
action partners for nucleotides in SL III of the UsnRNA,
Figure 6. Overall locations of protein–protein and protein–RNA cross-linking sites in Sm proteins, SPN1 and within the U1 particle. (A) Location of
the protein–protein cross-linking sites in SmD2, SmD3, SmB/B0. The Sm proteins are depicted as a heptameric ring structure in various colors.
Images were generated using PYMOL, and the coordinates of the respective proteins within the published U1 snRNP structure (22) available in the
PDB (PDBid: 3CW1). No coordinates are available for loop 4 of SmD2, SmB/B0 or for the C-terminus of SmD3. Note that only coordinates from
the a-C atoms were available in the PDB database. Yellow spheres mark the N- and C-terminal borders of loop 4 in SmD2, which was found to be
cross-linked to U1-70K. Green spheres mark the borders of the corresponding loop region 4 in SmB/B0 protein, which was found to cross-linked to
SNP1. The dark red sphere marks the last C-terminal amino acid in SmD3 for which coordinates were available. The subsequent amino acids in
SmD3 were found to be cross-linked to SPN1. (B) Domain structures of SPN1 with cross-linking sites. Images were generated using PYMOL and the
coordinates of SPN1 in the PDB (PDBid: 1XK5). SPN1 is shown with its co-crystallized cap-analogue structure (36,37). The orientation of the
domains of SPN1 is as found in complex with CRM1 (PDBid: 3GJX) with the structured C-terminus of SPN1. The N-terminal IBB domain is
colored in light grey, and the m3-Cap binding domain of SPN1 is shown in dark grey with the TMG cap in red superposed form (PDBid: 1XK5); the
cross-linking sites to SmB/B0 and SmD3 are marked in orange with the actual cross-linked amino acid shown as an orange sphere. The cross-linking
site to stem-loop III of U1 (SL III) is shown in red, and the actual cross-linked amino acid as a red sphere. The ﬂexible region linking the central
domain to the C-terminal residues is indicated as black dashed line. (C) Location of protein–protein and protein–RNA cross-linking sites identiﬁed
on U1snRNPs (according to PDBid: 3CW1). The RNA is shown in black, with the area of cross-link in SL III and TMG are depicted as red spheres.
The stem-loops I (SL I), SL III, and SL IV are indicated. Note that stem-loop II (SL II) has been truncated in order to obtain crystal structure (22).
The Sm proteins are shown as in panel A using the same color code, whereas the U1-C and U1-70k are depicted in light and dark grey, respectively.
The missing residues in U1-70k are indicated as dotted red line. Beginning and end point of cross-linked peptides are shown in colored spheres
according to panel A.
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spatial criterion required for bridging the distance
between the TMG and SL III (data not shown).
Taken together, our cross-linking data are in excellent
agreement with the recent low-resolution U1snRNP
crystal structure (22), and the overall quaternary arrange-
ment of its components, i.e. the orientation of the Sm
proteins and in particular the location of the 50 m3G cap
and stem-loop III on the so-called ‘back’ side of
U1snRNP (Figure 6C). These data support earlier sugges-
tions that structurally and functionally important regions
of the U1snRNP are located at one side of the U1snRNP.
Probing experiments with human U1 and U2snRNPs
bound to pre-mRNA in an early spliceosomal complex
demonstrated that only the backside is accessible to HO
radicals generated by the BABE reagent incorporated into
U2snRNA. On the basis of these results, it was suggested
that this particular site of U1snRNP is close to U2snRNP
when assembled into an early functional spliceosomal
complex (49). On the basis of our crosslinking data, this
side must be (at least partly) covered by SPN1 maybe as
part of the large import machinery, which dissociates
when it reaches the nucleus, to expose the back of the
particle so that U1snRNP can carry out its function in
pre-mRNA splicing. Importantly, the location of SPN1 on
this side also leaves enough freedom to accommodate the
additional factors of the UsnRNP import machinery
around the N-terminal part of SPN1 and the C-terminal
tails of the Sm proteins D3, B and D1.
Moreover, cross-linking of the N-terminal peptide of
U1-70K encompassing positions 33–46 to the Sm-D2
tryptic peptide encompassing positions 87–92 (loop 4,
see above) is highly consistent with the proposed path of
the N-terminus of U1 70K in the three-dimensional struc-
ture of Pomeranz Krummel et al. (22). In this structure,
the path of the U1 70K N-terminus was traced by crystal-
lization of seven SeMet derivatives of single methionine
mutation at positions L9M, I19M, E32M, I41M, E49M,
E61M, and I75M. In the electron density of the crystal
structure, the thus substituted N-terminus is between
I41(M) and E49(M) in contact to protein Sm D2. These
data again prove the high speciﬁcity of the protein–protein
cross-linking approach in order to decipher the spatial
arrangements within molecular assemblies.
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